Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

被引：0
|
作者：
Kivrane, Agnija [1 ,2 ]
Ulanova, Viktorija [1 ,2 ]
Grinberga, Solveiga [3 ]
Sevostjanovs, Eduards [3 ]
Viksna, Anda [2 ,4 ]
Pole, Ilva [4 ]
Ozere, Iveta [2 ,4 ]
Bogdanova, Ineta [4 ]
Zolovs, Maksims [2 ,5 ]
Bandere, Dace [2 ]
Ranka, Renate [1 ,2 ]
机构：
[1] Latvian Biomed Res & Study Ctr, Riga, Latvia
[2] Riga Stradins Univ, Riga, Latvia
[3] Latvian Inst Organ Synth, Riga, Latvia
[4] Riga East Univ Hosp, Ctr TB & Lung Dis, Upeslejas, Latvia
[5] Daugavpils Univ, Daugavpils, Latvia
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2023年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
NORPM-P33
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [41] New Biomarkers for Predicting Anti-Tuberculosis Drug-Induced Hepatotoxicity in Tunisian Patients with Tuberculosis
    Ben Mahmoud, L.
    Ghozzi, H.
    Hachicha, H.
    Kammoun, A.
    Zalila, N.
    Mahfoudh, N.
    Hammami, S.
    Hakim, A.
    Sahnoun, Z.
    Makni, H.
    Zeghal, Kh
    DRUG SAFETY, 2009, 32 (10) : 908 - 909
  • [42] Patterns Of Alanine Transaminase Rise In Tuberculosis Drug-Induced Hepatotoxicity
    Reddy, D.
    Weinberg, J.
    Moro, R.
    Feng, P. -J.
    Goldberg, S.
    Saukkonen, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [43] Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China
    Xu, Na
    Yang, Jing Xiang
    Yang, Jian
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (04) : 217 - 221
  • [44] Should Moxifloxacin Be Substituted for Isoniazid as a First-Line Antituberculosis Drug? Reply
    Dorman, Susan E.
    Johnson, John L.
    Chaisson, Richard E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (07) : 686 - 687
  • [45] Outcomes of the management for patients with antituberculosis drug-induced cutaneous adverse drug reactions
    Thongraung, W.
    Rerkpattanapipat, T.
    Pungrassami, P.
    ALLERGY, 2013, 68 : 385 - 385
  • [46] NAT2 polymorphism and clinical factors that increased antituberculosis drug-induced hepatotoxicity
    Noor, Nur Farhana Mohamed
    Salleh, Mohd Zaki
    Zim, Mohd Arif Mohd
    Abu Bakar, Zamzurina
    Noorizhab, Mohd Nur Fakhruzzaman
    Zakaria, Noor Izyani
    Lailanor, Muhammad Imran
    Teh, Lay Kek
    PHARMACOGENOMICS, 2022, 23 (09) : 531 - 541
  • [47] Protective Effect of Caffeic Acid Phenethyl Ester on Antituberculosis Drug-Induced Hepatotoxicity in Rats
    Aliosmanoglu, Cigdem
    Erbi, Halil
    Aliosmanoglu, Ibrahim
    Turkoglu, Mehmet Akif
    Ulger, Burak Veli
    Turkoglu, Ahmet
    Yuksel, Hatice
    INTERNATIONAL SURGERY, 2017, 102 (9-10) : 473 - 478
  • [48] Antituberculosis drug-induced hepatotoxicity - The role of hepatitis C virus and the human immunodeficiency virus
    Ungo, JR
    Jones, D
    Ashkin, D
    Hollender, ES
    Bernstein, D
    Albanese, AP
    Pitchenik, AE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : 1871 - 1876
  • [49] Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity
    Zhang, Jingwei
    Jiao, Lin
    Song, Jiajia
    Wu, Tao
    Bai, Hao
    Liu, Tangyuheng
    Zhao, Zhenzhen
    Hu, Xuejiao
    Ying, Binwu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [50] Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
    Sharma, Surendra K.
    Jha, Brajesh Kumar
    Sharma, Abhishek
    Sreenivas, V.
    Upadhyay, Vishwanath
    Jaisinghani, Chandrita
    Singla, Rohit
    Mishra, Hemant Kumar
    Soneja, Manish
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 144 : 924 - 928
12345